The study data have been uploaded to figshare and are accessible using the DOI: <https://doi.org/10.6084/m9.figshare.9932954.v1>.

Introduction {#sec005}
============

Globally, malaria is an important health threat with about 219 million cases and 435,000 associated deaths in the year 2017, approximately 92% of the cases and 93% of the deaths occurred in sub-Saharan Africa \[[@pone.0223869.ref001]\]. The remarkable decline in the global burden of malaria witnessed since the turn of the century appear to have stalled. The global fight against malaria has not only failed to make new gains since 2017, it has actually lost grounds in sub-Saharan Africa including Nigeria \[[@pone.0223869.ref001],[@pone.0223869.ref002]\]. Most malaria-related deaths occur within 48 hours of onset of symptoms, hence the need for early diagnosis and prompt treatment of cases with effective antimalarial drugs \[[@pone.0223869.ref001],[@pone.0223869.ref003]\]. It is currently recommended that every suspected malaria case be confirmed using light microscopy (gold standard) or Rapid Diagnostic Test (RDT) before treatment \[[@pone.0223869.ref004]--[@pone.0223869.ref007]\]. Operational complexities such as erratic electric power supply and dearth of expert malaria microscopists, have limited the use of light microscopy in malaria endemic countries like Nigeria. However, most of these challenges have been overcome by the introduction of mRDT leading to better targeting of malaria treatment \[[@pone.0223869.ref008]--[@pone.0223869.ref011]\]. Furthermore, quality controlled mRDTs used correctly have been shown to give results comparable or even better than light microscopy under routine conditions \[[@pone.0223869.ref012]--[@pone.0223869.ref016]\].

Despite the proven effectiveness of mRDTs in malaria diagnosis, health workers (HWs), especially in sub-Saharan Africa \[[@pone.0223869.ref017]\], sometimes prescribe antimalarial drugs for patients with negative mRDT results even when it is obvious that not giving such prescriptions will do no harm to the patient \[[@pone.0223869.ref017]--[@pone.0223869.ref019]\]. This inappropriate prescription could lead to unnecessary use of antimalarial drugs, economic wastage, increased risk of selection for drug resistant parasites and delayed detection of real cause of fever \[[@pone.0223869.ref017]\]. Studies have reported proportions of patients with negative mRDT results given antimalarial drug prescriptions in Nigeria and elsewhere to vary between 14% and 74% \[[@pone.0223869.ref017]--[@pone.0223869.ref021]\]. Although some studies have identified possible reasons why health workers prescribe antimalarial drugs for patients with negative mRDT results; most of these studies were either qualitative or simply elicited possible reasons for such prescriptions without evaluating the strength of influence of identified factors \[[@pone.0223869.ref017]--[@pone.0223869.ref019],[@pone.0223869.ref022],[@pone.0223869.ref023]\]. Some factors reported to influence HWs compliance with mRDT test results include HWs perception of mRDT, job cadre, work experience, training on malaria case management, knowledge of causes of fever, availability of algorithm to guide treatment decisions when test result is negative, patient expectation, and suspicion of treatment failure \[[@pone.0223869.ref011],[@pone.0223869.ref017],[@pone.0223869.ref018],[@pone.0223869.ref020],[@pone.0223869.ref023]\]. Hitherto these have not been explored in Ebonyi State, Nigeria.

Evidence has shown that the role of factors influencing performance of HWs vary with context and environment \[[@pone.0223869.ref024]\]. Furthermore, health workers' perception of mRDT \[[@pone.0223869.ref011],[@pone.0223869.ref017],[@pone.0223869.ref023]\] as well as their antimalarial prescription practices also vary with settings \[[@pone.0223869.ref020],[@pone.0223869.ref025],[@pone.0223869.ref026]\]. The 2018 WHO country-led 'High burden to High impact' approach, aimed at putting the global malaria control response back on track, in its pillar two emphasized use of strategic information to drive impact. This initiative while discouraging a one-size-fits-all approach to malaria control, encourages sub-national stratification of interventions based on evidence, to ensure well targeted response \[[@pone.0223869.ref002]\]. Ebonyi state has the highest prevalence of malaria in southeast Nigeria \[[@pone.0223869.ref027]\] and malaria is the most prevalent medical condition treated in healthcare facilities across the state \[[@pone.0223869.ref028]\]. Almost two decades after introduction of mRDT in malaria case management in Ebonyi state, no study was found to have explored health workers' perception of mRDT and their level of compliance with mRDT results in the state. Although earlier in 2013 and 2014, a nationwide cross-sectional survey provided some information on provider and patient perception of mRDT in Enugu, a neighbouring state in southeast Nigeria, evidence shows that Nigerian states have peculiarities and differ markedly in uptake of interventions \[[@pone.0223869.ref019],[@pone.0223869.ref029],[@pone.0223869.ref030]\]. This is evidenced in a recent study that examined the uptake of another malaria intervention in Nigeria, thus buttressing the need for state-specific information for evidence-based decision making \[[@pone.0223869.ref031]\].We therefore assessed health workers' perception of mRDT and factors influencing ACT prescription to patients with negative test results in Ebonyi state Nigeria; in order to provide state-specific support for improved management of malaria and non-malaria febrile illnesses.

Materials and methods {#sec006}
=====================

Study setting {#sec007}
-------------

This study was conducted in Ebonyi state, southeast Nigeria. Malaria is endemic in the state with perennial transmission. *Plasmodium falciparum* is the predominant parasite species \[[@pone.0223869.ref032]\]. The state has 13 local government areas (LGAs) including three urban and ten rural LGAs. The state has a projected population (2019) of 3,147,661 using a growth rate of 2.8% and 2006 population figure as the baseline \[[@pone.0223869.ref032],[@pone.0223869.ref033]\]. There are 555 registered healthcare facilities in the state at the comprising two tertiary healthcare facilities, 13 General hospitals (one in each LGA), 424 primary healthcare centers, 6 missionary hospitals and 110 small private health facilities \[[@pone.0223869.ref032]\]. The six missionary hospitals, located in six different rural LGAs, have capacity for light microscopy and malaria RDT and they provide healthcare for over 60% of the population within their catchment areas \[[@pone.0223869.ref033]\]. The secondary health facilities have capacity for light microscopy and RDT-based malaria diagnosis, while the PHC facilities only perform RDT-based malaria diagnosis. In the tertiary facility, mRDT is used for malaria diagnosis at the children outpatient (CHOP), children emergency (CHER), and a model comprehensive healthcare center located at Izzi LGA which serves a rural outpost for the tertiary facility. The other units in the hospital use malaria microscopy for diagnosis \[[@pone.0223869.ref032]\]. There were 11,187 health workers in the state including proprietary and patent medicine vendors, role model caregivers and traditional birth attendants, but only 2099 health workers were licensed to treat patients \[[@pone.0223869.ref032]\]. The average number of HWs licensed to treat patients in the different strata of healthcare facilities in the state are as follows: four community health workers (CHWs) in each PHC, six (medical doctors and nurses) in each General hospital, about 30 (doctors, nurses and CHWs) in each missionary hospital and 80 (doctors, nurses and CHWs) in the departments of the tertiary facility where mRDT is used for malaria diagnosis. Ebonyi State Malaria Elimination Programme (SMEP), with the support development partners, procure, store and distribute commodities (including mRDT and ACTs) for free diagnosis and treatment of malaria in 266 (out of the 439) public facilities and the six missionary hospitals in the state \[[@pone.0223869.ref032]\]. The SMEP train and supervise health workers in supported facilities and also conduct quarterly malaria diagnosis quality assurance in these facilities \[[@pone.0223869.ref032]\].

Study design and population {#sec008}
---------------------------

A cross-sectional study was conducted among health workers whose job description includes diagnosis and treatment of febrile patients in selected private (missionary) and public healthcare facilities supported by SMEP to carry out mRDT-based malaria diagnosis free of charge to clients in Ebonyi State between February and April, 2017.

Sample size determination {#sec009}
-------------------------

The Cochran formular\[[@pone.0223869.ref034]\] with design effect (DEFF) to account for the multistage cluster design was used to calculate the minimum sample size \[[@pone.0223869.ref035]\]: $$n\ \left( minimum\ sample\ size \right) = DEFF*\frac{\left( Z_{\alpha} \right)^{2}pq}{d^{2}}$$ $$DEFF\ \left( {Design\ effect} \right) = 1 + \left( {m - 1} \right)*ICC$$

m = average number of respondents per cluster (health facility; PHCs/ General hospital) = 4

ICC = Intraclass correlation coefficient = 0.042 \[[@pone.0223869.ref036]\]

Z~α~ = standard normal deviate at 95% confidence level = 1.96

p = 0.26 (proportion of health workers who reported prescribing ACTs for patients with negative mRDT results) \[[@pone.0223869.ref019]\]

q = compliment of p i.e. (1-p) = 0.74

d = level of precision set at 0.05

Applying the formular, n = \[1+ (4--1) x 0.042\] x \[(1.96)^2^x 0.26 x 0.74\]/0.05^2^

n = 1.126 x 295.65 = 332.90

The target population (health workers qualified to treat suspected malaria patients in public and private facilities in Ebonyi State) is finite (N = 2099).\[[@pone.0223869.ref032]\] Therefore applying finite population correction and adjusting for anticipated non-response of 5%, gave a required minimum sample size of 302.60 respondents. We therefore recruited 303 healthcare workers for the survey.

Sampling technique {#sec010}
------------------

A three-stage sampling process ([Fig 1](#pone.0223869.g001){ref-type="fig"}) was used to select the study participants. In stage one (selection of LGAs); two LGAs were selected from each of the three senatorial districts in the state by simple random sampling (SRS) giving six LGAs. In stage two (selection of health facilities), healthcare facilities were first stratified according to facility types: PHCs, General hospital, tertiary facility and missionary hospital. We then selected five PHCs from each of the six selected LGAs by SRS. The only general hospital located in each of the six selected LGAs was included. Three missionary hospitals were randomly selected from a frame of six missionary hospitals in the state. The only teaching hospital in the state was also included giving a total of 40 health facilities (30 PHCs, 6 General hospitals, 3 missionary hospitals and 1 teaching hospital). At the facility level, all consenting eligible HWs were recruited for the PHCs, General hospitals and missionary hospital. For the tertiary facility however, to ensure representativeness, the allocated sample size was proportionately assigned to the three departments of the hospital where mRDT is used and eligible participants in each department recruited consecutively base on availability during study period until sample size was achieved.

![Flowchart of the sampling process.](pone.0223869.g001){#pone.0223869.g001}

Data collection {#sec011}
---------------

The researcher and four trained research assistants (university graduates who had not worked at the state malaria program) administered an open data kit (ODK) based pre-tested semi-structured questionnaire on participants. The questionnaire was adapted from similar studies \[[@pone.0223869.ref011],[@pone.0223869.ref018],[@pone.0223869.ref019],[@pone.0223869.ref021],[@pone.0223869.ref023]\] and used to collect data on health workers' perception of mRDT, compliance with test results, training on malaria case management, availability of supportive supervision and job aids at work.

Data processing and analysis {#sec012}
----------------------------

Data were entered into ODK collect on smart phone during interview. Skip logics, constraints and relevant-fields commands were used to limit wrong entries, incomplete entries and inconsistencies. Data were extracted from the mobile phones and converted to MS Excel (xls) format using ODK briefcase, cleaned and then exported to Epi Info version 7 for analysis. Descriptive statistics were summarized as frequency and percentages. Perception was assessed with 18 Likert scale questions with minimum and maximum obtainable total scores of 18 and 90 respectively. Computed scores of 72 and above (corresponding to agree or strongly agree for positively worded perception questions and vice versa) were graded as good perception while scores below 72 were graded as poor perception. Chi-squared test was used to determine association between ACT prescription to patients with negative RDT results and independent variables at 5% level of significance. Variables that were significant at α \<0.01 during bivariate analysis were included in the logistic regression model using a step-wise approach. Results of the independent predictors of ACT prescription to patients with negative mRDT results were expressed using adjusted odds ratio and 95% confidence interval.

Ethical considerations {#sec013}
----------------------

Ethical approval (Ref: E7A/029/17/3) for the study was obtained from the Research Ethics Committees of Ebonyi State Ministry of Health and written permission obtained from the Ebonyi State Hospital Services Management Board. Written Informed consent was obtained from each participant following explanations of the study aims, procedures, voluntariness, benefits and risks. Data privacy and confidentiality was maintained throughout the study.

Results {#sec014}
=======

Sociodemographic characteristics of prescribers {#sec015}
-----------------------------------------------

All 303 respondents correctly completed the questionnaires giving a response rate of 100%. The mean age of respondents was 34.6 ± 9.4 years, the majority 229 (75.6%) were females, and 180 (59.4%) have practiced (as certified prescribers) for at most 10 years. Majority 180 (59.4%) were Community health workers, 51 (16.8%) were registered nurses/ mid-wives and 67 (22.1%) were medical doctors of different cadres. Thirty-nine percent of the respondents work in PHCs, 12.5% in General hospitals, 21.1% in tertiary facility and 27.4% in missionary hospitals ([Table 1](#pone.0223869.t001){ref-type="table"}).

10.1371/journal.pone.0223869.t001

###### Sociodemographic characteristics of health workers, Ebonyi state (N = 303).

![](pone.0223869.t001){#pone.0223869.t001g}

  Characteristics                                                     Frequency   Percentage
  ------------------------------------------------------------------- ----------- ------------
  **Age groups in years**                                                         
      \< 30                                                           97          32.0
      30--39                                                          114         37.6
      40--49                                                          75          24.7
      ≥ 50                                                            17          5.7
  **Sex**                                                                         
      Females                                                         229         75.6
      Males                                                           74          24.4
  **Professional Cadre**                                                          
      Community Health Workers[\*](#t001fn001){ref-type="table-fn"}   180         59.4
      Registered Nurses/ Midwives                                     51          16.8
      Medical Doctors                                                 67          22.1
      Others[\*\*](#t001fn002){ref-type="table-fn"}                   5           1.7
  **Highest Educational Qualification**                                           
      SSCE/ Certificates                                              98          32.3
      Diploma                                                         113         37.3
      Graduate degree                                                 76          25.1
      Postgraduate Degree[\*\*\*](#t001fn003){ref-type="table-fn"}    16          5.3
  **Years of Experience**                                                         
      ≤ 10                                                            180         59.4
      11--20                                                          90          29.7
      21--30                                                          28          9.2
      \> 30                                                           5           1.7
  **Distribution of respondents by facility type**                                
      PHCs                                                            118         39.0
      General Hospitals                                               38          12.5
      Tertiary facility                                               64          21.1
      Missionary hospitals                                            83          27.4

\* Includes (Junior) CHEWS, Environmental Health Officers, Lab Technicians, Auxiliary Nurses, CHOs etc.

\*\*Others = B. Ed, BSc and BMLS.

\*\*\*Includes Postgraduate Medical College Fellowships and Memberships, MPH. MSc.

Health workers' perception of Malaria-RDT {#sec016}
-----------------------------------------

[Table 2](#pone.0223869.t002){ref-type="table"} shows health workers' perception of mRDT. While 277 (91.4%) of respondents agreed that febrile patients should always be tested before treatment, 58 (19.1%) see the use of clinical signs and symptoms alone as an accurate way of confirming malaria. Although 243 (80.2%) of respondents agreed that mRDT is an effective way of diagnosing malaria, 240 (79.2%) believed microscopy is more effective than mRDT. Furthermore, 262 (86.5%) of respondents said they fully trust a positive mRDT result as confirming malaria diagnosis whereas only 121 (39.9%) fully trusts a negative mRDT result as ruling out malaria diagnosis. Moreover, 216 (71.3%) of respondents said they will prescribe antimalarial drugs for patients with negative mRDT result if they have strong clinical suspicion of malaria while 192 (63.4%) said they will prescribe if they suspect patient has a low plasmodium parasite level not detected by the mRDT. Fifty-one (16.8%) of respondents said they will prescribe antimalarial drugs to patients who tested negative on mRDT if they are pressurized by patients to prescribe.

10.1371/journal.pone.0223869.t002

###### Health workers' perception of malaria rapid diagnostic test, Ebonyi state, 2017.

![](pone.0223869.t002){#pone.0223869.t002g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Statements                                                                         [\*](#t002fn001){ref-type="table-fn"}Agree\   [†](#t002fn002){ref-type="table-fn"}Disagree\
                                                                                     n (%)                                         n (%)
  ---------------------------------------------------------------------------------- --------------------------------------------- -----------------------------------------------
  Clinical symptoms and signs accurate in confirming malaria diagnosis               58 (19.1)                                     245 (80.9)

  A**lways** confirm malaria diagnosis with lab test before treatment                277 (91.4)                                    26 (8.6)

  mRDT effective in confirming malaria diagnosis                                     243 (80.2)                                    60 (19.8)

  Microscopy is more effective than mRDT                                             240 (79.2)                                    63 (20.8)

  Malaria-RDT is more effective than microscopy                                      38 (12.5)                                     265 (87.5)

  Microscopy and mRDT are **equally** effective                                      130 (42.9)                                    173 (57.1)

  I fully trust a **positive** mRDT result                                           262 (86.5)                                    41 (13.5)

  I fully trust a **negative** mRDT result                                           121 (39.9)                                    182 (60.1)

  More confident in positive mRDT result than in a negative one                      266 (87.8)                                    37 (12.2)

  More confident in a negative mRDT result than in a positive one                    17 (5.6)                                      286 (94.4)

  Equally confident in a positive and a negative mRDT result                         129 (42.6)                                    174 (57.4)

  No confidence in both positive and negative mRDT result                            5 (1.7)                                       298 (98.3)

  **Will prescribe antimalarial drugs to a patient with negative mRDT result if:**                                                 

  I clinically suspect malaria                                                       216 (71.3)                                    87 (28.7)

  patient reported taking antimalarial drug before presentation to me                141 (46.5)                                    162 (53.5)

  I suspect patient has low parasite level not detected by mRDT                      192 (63.4)                                    111 (36.6)

  patient pressurizes me to prescribe                                                51 (16.8)                                     252 (83.2)

  I don't trust the mRDT I am using                                                  145 (47.9)                                    158 (52.1)

  I don't trust my skills in performing mRDT                                         115 (38.0)                                    188 (62.0)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Agree = Agree + strongly agree

†Disagree = Disagree + strongly disagree + Neutral

Overall, 114 (37.6%) respondents have poor perception of malaria rapid diagnostic test. This comprises 19 (16.1%) of prescribers in the PHCs, 12 (31.6%) of those in the General hospitals, 47 (73.4%) of those in the tertiary facility and 36 (43.4%) of those in the missionary hospitals ([Fig 2](#pone.0223869.g002){ref-type="fig"}).

![Health workers' perception of mRDT and prescription of ACTs for patients with negative RDT results, Ebonyi state (N = 303).](pone.0223869.g002){#pone.0223869.g002}

Prescription of ACTs for patients with negative RDT results {#sec017}
-----------------------------------------------------------

Overall, 154 (50.8%) of respondents reported prescribing ACTs to patients with negative RDT results within the six months preceding the interview. This comprised 50 (42.4%), 18 (47.4%), 51 (79.7%) and 35 (42.2%) of respondents from PHCs, General hospitals, tertiary facility and missionary hospitals respectively ([Fig 2](#pone.0223869.g002){ref-type="fig"}).

Factors influencing ACT prescription for patients with negative mRDT results {#sec018}
----------------------------------------------------------------------------

At bivariate analysis ([Table 3](#pone.0223869.t003){ref-type="table"}), the following variables were found to be significantly associated with ACT prescription to patients with negative RDT results: prescriber's professional cadre, perception of RDT, training on other causes of fever and health facility level (alpha = 5%). Variables not significantly associated with ACT prescription to patients with negative RDT results include prescriber's sex, professional experience, health facility type, availability of algorithm on what to do when RDT result is negative, training on malaria case management with RDT, duration of such training, training on negotiation skills and so on (alpha = 5%). However, at multivariate analysis ([Table 3](#pone.0223869.t003){ref-type="table"}) only prescriber's perception of mRDT and health facility type were found to be independent predictors of ACT prescription to patients with negative mRDT result. Prescribers with poor perception of mRDT had 5.6 times the odds of prescribing ACTs to patients with negative RDT results compared to those with good perception of mRDT (AOR = 5.60, 95% C.I = 3.16--9.91). Also, prescribers in public facilities had 2.8 times the odds of prescribing ACT for patients with negative mRDT results compared to those in the private facilities (AOR = 2.81, 95% C.I = 1.44--5.46).

10.1371/journal.pone.0223869.t003

###### Factors influencing ACT prescription for patients with negative mRDT results, Ebonyi state.

![](pone.0223869.t003){#pone.0223869.t003g}

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Factors                                               Prescribe ACT when RDT result is negative   Crude OR\    Adjusted OR\                                               
                                                                                                    (95% C.I)    (95% CI)                                                   
  ----------------------------------------------------- ------------------------------------------- ------------ ---------------------------------------------------------- -----------------------------------------------------------
  **Type of health facility**                                                                                                                                               

  Public                                                119 (77.3)                                  101 (67.8)   1.6 (0.8--2.7) [\*\*\*](#t003fn003){ref-type="table-fn"}   **2.7 (1.4--5.4)[\*\*](#t003fn002){ref-type="table-fn"}**

  Private (*ref*)                                       35 (22.7)                                   48 (32.2)    1                                                          

  **Level of health facility**                                                                                                                                              

  Secondary/ Tertiary                                   104 (67.5)                                  81 (54.4)    1.8 (1.1--2.8) [\*\*](#t003fn002){ref-type="table-fn"}     1.7 (0.8--3.5)

  Primary (*ref*)                                       50 (32.5)                                   68 (45.6)    1                                                          

  **Professional Cadre**                                                                                                                                                    

  Medical Doctors, Nurses/ Midwives                     72 (46.7)                                   51 (34.2)    1.7 (1.1--2.7) [\*\*](#t003fn002){ref-type="table-fn"}     1.3 (0.7--2.5)

  Community Healthcare workers (*ref*)                  82 (53.3)                                   98 (65.8)    1                                                          

  **Years of Experience**                                                                                                                                                   

  ≤ 5                                                   55 (35.7)                                   52 (34.9)    1.0 (0.7--1.7)                                             

  \> 5 (*ref*)                                          99 (64.3)                                   97 (65.1)    1                                                          

  **Sex**                                                                                                                                                                   

  Female                                                110 (71.4)                                  119 (79.9)   0.6 (0.4--1.1)                                             

  Male (*ref*)                                          44 (28.6)                                   30 (20.1)    1                                                          

  **Malaria case management training (CMT) with RDT**                                                                                                                       

  Yes                                                   85 (55.2)                                   85 (57.1)    0.9 (0.6--1.5)                                             

  No (*ref*)                                            69 (44.8)                                   64 (42.9)    1                                                          

  **Duration of malaria CMT with RDT**                                                                                                                                      

  \< 3 days                                             123 (79.9)                                  108 (72.5)   1.5 (0.9--2.6)                                             

  \> 3 days (*ref*)                                     31 (20.1)                                   41 (27.5)    1                                                          

  **Training on other causes of fever**                                                                                                                                     

  Yes                                                   69 (44.8)                                   48 (32.2)    1.7 (1.1--2.7) [\*\*](#t003fn002){ref-type="table-fn"}     1.3 (0.7--2.2)

  No (*ref*)                                            85 (55.2)                                   101 (67.8)   1                                                          

  **Training on negotiation skills**                                                                                                                                        

  No                                                    87 (56.5)                                   80 (53.7)    1.1 (0.7--1.8)                                             

  Yes (*ref*)                                           67 (43.5)                                   69 (46.3)    1                                                          

  **Perception of mRDT**                                                                                                                                                    

  Poor                                                  87 (56.5)                                   27 (18.1)    5.9 (3.4--9.9) [\*](#t003fn001){ref-type="table-fn"}       **5.9(3.4--10.5)[\*](#t003fn001){ref-type="table-fn"}**

  Good (*ref*)                                          67 (43.5)                                   122 (81.9)   1                                                          

  **Supportive Supervision available**                                                                                                                                      

  No (*ref*)                                            79 (51.3)                                   84 (56.4)    1                                                          

  Yes                                                   75 (48.7)                                   65 (43.6)    0.8 (0.5--1.3)                                             

  **Algorithm when RDT is negative**                                                                                                                                        

  No                                                    114 (74.0)                                  99 (66.4)    1.4 (0.9--2.4)                                             

  Yes (*ref*)                                           40 (26.0)                                   50 (33.6)    1                                                          

  **Quality control checks available**                                                                                                                                      

  No                                                    36 (23.4)                                   31 (20.8)    1.2 (0.7--2.0)                                             

  Yes (*ref*)                                           118 (76.6)                                  118 (79.2)   1                                                          

  **Feedbacks on mRDT Quality control**                                                                                                                                     

  No                                                    38 (24.7)                                   38 (25.5)    1.0 (0.6--1.6)                                             

  Yes (*ref*)                                           116 (75.3)                                  111 (74.5)   1                                                          
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Significant at 0.1%;

\*\*Significant at 5%;

\*\*\*Significant at 10%;

Discussion {#sec019}
==========

The findings from this study showed that about one-third of the prescribers have poor perception of mRDT and this situation was worse in the tertiary facilities than other health facilities in Ebonyi state. Health worker's poor perception of mRDT was reflected in the level of reported wrong prescription practices found in this study. Similar responses have been reported in other studies \[[@pone.0223869.ref010],[@pone.0223869.ref018]\]. Expectedly, health workers with poor perception of mRDT were likely to treat suspected malaria patients presumptively or even prescribe ACTs to patients with negative mRDT results. It is also evident in the current study that almost all the respondents agreed that it is important to confirm malaria diagnosis before treatment and a slightly lesser proportion agreed that mRDT is an effective way of confirming malaria diagnosis; it is then surprising that three-quarter of the respondents still said they will prescribe ACT for a patient with negative mRDT result if patient's signs and symptoms suggest malaria. This may be explained by a finding from this study that only few respondents fully trust a negative mRDT result as truly ruling out malaria, hence the temptation to go ahead with ACT prescription.

This study further found that four out of every five respondents expressed more confidence in a positive mRDT result than in a negative one. This is expected as a positive mRDT result in a febrile patient supports the clinical suspicion that necessitated the test. Similar finding was reported by a study assessing the effect of RDT results on health workers antimalarial prescription practices in selected PHCs in Uganda \[[@pone.0223869.ref010]\]. It is very important to address this seeming lack of trust in negative mRDT result by health workers as this is key to reducing inappropriate ACT prescription for patients with negative mRDT results. Interestingly, 13.5% of health workers expressed distrust for even a positive mRDT result in a febrile patient. A plausible explanation for this finding is the inherent poor perception of mRDT expressed by some health workers especially doctors in tertiary facilities. An ingrained negative bias towards mRDT results could make such prescribers indifferent to any mRDT result even when it supports their clinical suspicion. Another common unfavourable perception expressed by many prescribers in the state is that microscopy is more effective than mRDT in the diagnosis of malaria. This finding is different from the report from a study conducted among community health workers shortly after mRDT introduction in a neighbouring state where the majority of the interviewed prescribers perceived mRDT to be more effective than microscopy and clinical diagnosis \[[@pone.0223869.ref037]\]. The enthusiasm following initial introduction of mRDT may explain the favourable perception in the study above. Furthermore, our study included health workers from secondary and tertiary healthcare facilities who may likely perceive mRDT differently from lower level workers in PHCs.

This study also found prescribers' perception of mRDT to be a strong predictor of ACT prescription to patients with negative mRDT results. Prescribers with poor perception of mRDT were strikingly more likely to prescribe ACTs to patients with negative mRDT result compared to those with good perception. This further buttresses the fact that poor perception of mRDT is an important root cause that must be addressed if health workers are to stop prescribing ACT to patients with negative mRDT results. Various studies have reported health worker perception of mRDT to be a predictor of ACT prescription to patients with negative mRDT results \[[@pone.0223869.ref017],[@pone.0223869.ref018],[@pone.0223869.ref023]\]. Furthermore, facility type was also found to be a predictor of inappropriate ACT prescription to patients with negative mRDT results. Prescribers in private (missionary) hospitals were found to be less likely to prescribe ACTs to patients with negative mRDT results compared to those in public facilities. However, since ACT prescription was an elicited response, it is possible that prescribers in the private hospitals were a bit more conservative with the truth regarding their actual prescription practices.

Limitations {#sec020}
-----------

Due to the cross-sectional nature of this study, some respondents might be tempted to report desired rather than actual practice of ACT prescription to patients with negative mRDT results. However, in order to minimize this source of bias, the respondents were re-assured that their responses will remain confidential and anonymous as no identifier information was collected.

Conclusions {#sec021}
===========

Poor perception of mRDT was common among health workers in Ebonyi state and was a determinant of healthcare workers' prescription of ACTs for patients with negative mRDT results. Health workers who practise in public facilities especially tertiary facility were more likely to prescribe ACTs to patients with negative mRDT results. We recommend deployment of facility-type tailored interventions aimed at improving HW perception of mRDT and compliance with negative test results.

Supporting information {#sec022}
======================

###### Study questionnaire with informed consent page.

(DOCX)

###### 

Click here for additional data file.
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PLOS ONE

Dear Dr OBI,

Thank you for submitting your manuscript to PLoS ONE. After careful consideration, we felt that your manuscript requires substantial revision, following which it can possibly be reconsidered, thus governing the decision of a "major revision". As point-out by the reviewer \#2, the research question has been addressed multiple times in malaria RDT literature. Major concerns were related to methodological weaknesses in both the synthesis of the literature and the methods. Consequently, there are fundamental topics that need to be clarified and adjusted in the MS.  We therefore ask that you revise your manuscript paying close attention to the specific points raised by the reviewer \#2.  For your guidance, a copy of the reviewers\' comments was included below.

We would appreciate receiving your revised manuscript by July 30. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Luzia Helena Carvalho, Ph.D.

Academic Editor

PLOS ONE

**Journal Requirements:**

1\. When submitting your revision, we need you to address these additional requirements.

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The paper is well written and has addressed an important element affecting the use of RDTs in their area of practice.

Reviewer \#2: The authors present the findings of a study that aims to assess the perceptions\' of health workers towards malaria rapid diagnostic tests (mRDTs). In addition it also seeks to explore the characteristics that might influence compliance with test results This is an important public health paper that is generally well-written with a clear research question and reasoned structure to the paper. However, this research question has been addressed multiple times in the mRDT literature and it is unclear what the original research findings of this article are. THere are also methodological weaknesses in both the synthesis of the literature and the methods. The major and minor comments are outlined below which should be addressed before publication.

Major comments:

Introduction:

1\) It is unclear from the introduction what this study adds to the existing literature on mRDT compliance. The references 14, 22-26 already indicate substantial evidence related to mRDTs and it makes one question what additional value the stratification of these results add to the existing literature. I would encourage the authors to provide a more critical appraisal of the existing literature, its\' strengths and weaknesses and present more clear the current knowledge gaps.

Methods:

1\) Page 7: The sample size calculation is unclear, for example what was the finite population and design effect used?

2\) How was clustering within healthcare facilities accounted for?

3\) It has not been stated how the variables used for adjustment were selected a priori were they all at the 5% level of significance.?

Results:

1\) It was also interesting to note that 13.5% indicated that they did not trust positive results. This finding is also significant and requires some reflection in the discussion.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: Yes: SHAM LAL

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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7 Sep 2019

Reviewers' comments and authors' responses

Section: Introduction (Justification for the study)

Comments:

1\) It is unclear from the introduction what this study adds to the existing literature on mRDT compliance. The references 14, 22-26 already indicate substantial evidence related to mRDTs and it makes one question what additional value the stratification of these results add to the existing literature. I would encourage the authors to provide a more critical appraisal of the existing literature, its\' strengths and weaknesses and present more clear the current knowledge gaps.

Authors' response:

The authors have carried out a substantial revision and reorganisation of this section in view of reviewer's observations. This section now brings out more clearly gaps in existing literature which are filled by our study. Although some studies have identified possible reasons why health workers prescribe antimalarial drugs for patients with negative mRDT results, most of these studies were either qualitative or simply elicited possible reasons for such prescriptions without evaluating the strength of influence of identified factors.

Furthermore, the 2018 WHO country-led 'High burden to High impact' approach, aimed at putting the global malaria control response back on track, in its pillar two emphasized use of strategic information to drive impact. This initiative while discouraging a one-size-fits-all approach to malaria control, encourages subnational stratification of interventions based on evidence, to ensure well targeted response. Moreover, a subnational profiling analysis for uptake of another malaria intervention revealed regional differences as the main predictor of differences in uptake, buttressing the need for state-specific information to support evidence-based decision making. Although Ebonyi state has the highest prevalence of malaria in southeast Nigeria and malaria is the most prevalent medical condition treated in healthcare facilities across the state, no study was found to have explored health workers' perception of mRDT and their level of compliance with test results almost two decades after mRDT introduction in the state.

Our study identified health workers' perception of mRDT and the type of facility (public or private) as the predictors of ACT prescription to patients with negative mRDT result in Ebonyi. We also stratified health workers perception of mRDT and their prescription practices according to facility types to facilitate targeted intervention aimed at improving HWs perception of mRDT and compliance with test results for more impact.

This section now reads:

'Studies have reported proportions of patients with negative mRDT results given antimalarial drug prescriptions in Nigeria and elsewhere to vary between 14% and 74% \[17--21\]. Although some studies have identified possible reasons why health workers prescribe antimalarial drugs for patients with negative mRDT results; most of these studies were either qualitative or simply elicited possible reasons for such prescriptions without evaluating the strength of influence of identified factors \[17--19,22,23\]. Some factors reported to influence HWs compliance with mRDT test results include HWs perception of mRDT, job cadre, work experience, training on malaria case management, knowledge of causes of fever, availability of algorithm to guide treatment decisions when test result is negative, patient expectation, and suspicion of treatment failure \[11,17,18,20,23\]. Hitherto these have not been explored in Ebonyi State, Nigeria.

Evidence has shown that the role of factors influencing performance of HWs vary with context and environment \[24\]. Furthermore, health workers' perception of mRDT \[11,17,23\] as well as their antimalarial prescription practices also vary with settings \[20,25,26\]. The 2018 WHO country-led 'High burden to High impact' approach, aimed at putting the global malaria control response back on track, in its pillar two emphasized use of strategic information to drive impact. This initiative while discouraging a one-size-fits-all approach to malaria control, encourages sub-national stratification of interventions based on evidence, to ensure well targeted response \[2\]. Ebonyi state has the highest prevalence of malaria in southeast Nigeria \[27\] and malaria is the most prevalent medical condition treated in healthcare facilities across the state \[28\]. Almost two decades after introduction of mRDT in malaria case management in Ebonyi state, no study was found to have explored health workers' perception of mRDT and their level of compliance with mRDT results in the state. Although earlier in 2013 and 2014, a nationwide cross-sectional survey provided some information on provider and patient perception of mRDT in Enugu, a neighbouring state in southeast Nigeria, evidence shows that Nigerian states have peculiarities and differ markedly in uptake of interventions \[19,29,30\]. This is evidenced in a recent study that examined the uptake of another malaria intervention in Nigeria, thus buttressing the need for state-specific information for evidence-based decision making \[31\].We therefore assessed health workers' perception of mRDT and factors influencing ACT prescription to patients with negative test results in Ebonyi state Nigeria; in order to provide state-specific support for improved management of malaria and non-malaria febrile illnesses.'

Kindly refer to pages 4 - 6, lines 70 - 100 in the clean manuscript.

Section: Methods

Comments:

1\) Page 7: The sample size calculation is unclear, for example what was the finite population and design effect used?

Authors\' response:

More details on the sample size calculation has been provided to improve clarity. This section now clearly shows the finite target population (health workers qualified to treat suspected malaria patients in public and private facilities in Ebonyi State N= 2099) and how we arrived at the design effect used.

Kindly refer to pages 8 and 9, lines 135 - 153 in the clean manuscript.

2\) How was clustering within healthcare facilities accounted for?

Authors\' response:

More information has been provided here for more clarity. Clustering within healthcare facilities was accounted for by applying design effect (DEFF) calculated using the average cluster size (m) and referenced intraclass correlation coefficient (ICC).

Formular used was (DEFF=1+(m-1)\*ICC).

Kindly refer to page 8, lines 138 - 142 in the manuscript.

3\) It has not been stated how the variables used for adjustment were selected a priori were they all at the 5% level of significance?

Authors\' response:

Variables that were significant at α \<0.01 during bivariate analysis were included in the logistic regression model using a step-wise approach. Results of the independent predictors of ACT prescription to patients with negative mRDT results were expressed using adjusted odds ratio and 95% confidence interval.

Kindly refer to page 11, lines 188 - 191 in the manuscript.

Section: Results

Comments:

1\) It was also interesting to note that 13.5% indicated that they did not trust positive results. This finding is also significant and requires some reflection in the discussion.

Authors\' response: Thank you for this important observation. We have reflected this finding in the discussion as suggested.

Kindly refer to pages 18 and 19, lines 273 - 278 in the manuscript.

Academic editor's comments and authors' responses

Comments:

1\. As point-out by the reviewer \#2, the research question has been addressed multiple times in malaria RDT literature.

Authors\' response: The authors have carried out a substantial revision of the introduction section. This section now brings out more clearly gaps in existing literature which are filled by our study.

Kindly refer to pages 4 - 6, lines 70 - 100 in the clean manuscript.

2\. Major concerns were related to methodological weaknesses in both the synthesis of the literature and the methods. Consequently, there are fundamental topics that need to be clarified and adjusted in the MS. We therefore ask that you revise your manuscript paying close attention to the specific points raised by the reviewer \#2.

Authors\' response: The concerns raised by the second reviewer regarding literature synthesis and methodology (sample size calculation, accounting for intra-cluster correlation and the level of statistical significance for adjustment) have been addressed by providing more information for better clarity in the relevant sections of the manuscript as referenced above.

Kindly refer to pages 8 and 9, lines 135 - 153 in the clean manuscript.

3\. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

Authors\' response: There are no changes in our financial disclosure.

4\. Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.

A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.

An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Authors\' response: We have included a rebuttal letter, revised manuscript with tracked changes and the clean manuscript in our submission as requested.

Journal requirements: comments and authors' responses

Comments:

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and <http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

Authors\' response: The manuscript has been revised to ensure it meets PLOS ONE's style requirements using the templates provided.

2\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Authors\' response: There are no changes to our Data Availability statement.

###### 

Submitted filename: Response to Reviewers_Obi, IF.docx

###### 

Click here for additional data file.
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PONE-D-19-15506R1

Dear Dr. OBI,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. At that time, the reference 19 should be adjusted (Reference 19, first author should be Mokuolu OA and not OOA).  When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Luzia Helena Carvalho, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: The authors have addressed the comments of the Reviewers and manuscript is much improved. Specifically they have justified the need for the a subnational level experience to guide the understanding of RDT use. They have also provided clarity on the sampling procedure and have taken some deeper dive on the factors influencing HW prescription preferences.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No
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Dear Dr. Obi:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

For any other questions or concerns, please email <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Luzia Helena Carvalho

Academic Editor

PLOS ONE
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